Higher sales in most of its businesses contributed to a 4% increase in comparable sales for Philips Healthcare in its third quarter.
For the period (end-September 30), the Andover, MA-based vendor had comparable sales of 2.1 billion euros ($2.9 billion U.S.), compared with the 1.8 billion euros ($2.5 billion U.S.) reported in the third quarter of 2009.
Philips had third-quarter earnings before interest, taxation, and amortization (EBITA) of 282 million euros ($392.4 million U.S.), up from EBITA of 175 million euros ($243.5 million U.S.) in the same quarter last year.
Higher sales were produced by Philips' home healthcare solutions and patient care and clinical informatics units. On a regional basis, North American comparable sales were broadly in line with the third quarter of 2009, while markets outside of North America were up 7%, Philips said. The company also noted that key emerging markets turned in double-digit growth in comparable sales.
In other positive developments, currency-comparable equipment order intake climbed 7%, including notable improvements in the firm's imaging systems division. North American equipment orders climbed 11%, while order intake outside of North America was 2% higher (including 20% equipment order growth in emerging markets), Philips said.
Related Reading
Philips teams with DHS Systems, October 12, 2010
Philips nets PET/CT award, September 16, 2000
Philips awarded 2 telehealth contracts, August 31, 2010
Philips unveils iE33 enhancements, August 30, 2010
Philips debuts point-of-care ultrasound unit, August 26, 2010
Copyright © 2010 AuntMinnie.com












![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)





